Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance.

There is no fulltext present in this item.

Title:	Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance.
Author(s):	Groot, N.L. de; Haalen, H.G. van; Spiegel, B.M.; Laine, L.; Lanas, A.; Jaspers Focks, J. ; Siersema, P.D.; Oijen, M.G. van
Publication year:	2013
Source:	Cardiovascular Drugs and Therapy, vol. 27, iss. 4, (2013), pp. 341-357
ISSN:	0920-3206
DOI:	https://doi.org/10.1007/s10557-013-6448-y
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/119281
Display more details
Subject:	NCEBP 14: Cardiovascular diseases
Organization:	Cardiology Gastroenterology
Journal title:	Cardiovascular Drugs and Therapy
Volume:	vol. 27
Issue:	iss. 4
Page start:	p. 341
Page end:	p. 357